In NSABP B-18, there was a nonsignificant trend towards increased ipsilateral breast tumor recurrence (IBTR), 13% in the NST arm versus 10% in the adjuvant arm [ 34 ].
1
—
—
In NSABP B-18, there was a nonsignificant trend towards increased ipsilateral breast tumor recurrence (IBTR), 13% in the NST arm versus 10% in the adjuvant arm [ 34 ].